1 Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol. 2013; 24(4):878–88.
2 Carr BR, Bradshaw KD. Disorders oft he ovary and female reproductive tract. In: Harrisons Principles of Internal Medicine 15th Edition, Volume II. Lippincott Williams & Wilkins, Inc.; 2001..
3 Gilligan TD, Hayes DF, Seidenfeld J, Temin S. ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors. J Oncol Pract. 2010;6(4):199–202.
4 Ballieux BE, Weijl NI, Gelderblom H, van Pelt J, Osanto S. False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature. Oncologist. 2008;13(11):1149–54.
5 Cathomas R, Helbling D, Stenner F, Rothermundt C, Rentsch C, Shahin O et al. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkly. 2010;140(25-26):356–69.
6 Knight AK, Bingmann T, Cole L, Cunningham-Rundles C, Frequent false positive beta human chorionic gonadotropin tests in immunglobulin A deficiency, Clin Exp Immunol. 2005;141(2):333–7.
7 Garnick MB. Spurious Rise in Human Chorionic Gonadotropin Induced by Marihuana in Patients with Testicular Cancer. N Engl J Med. 1980;303:1177.
9 O’Connor JF, Birken S, Lustbader JW, Krichevsky A, Chen Y, Canfield RE. Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocr Rev. 1994;15(5):650–83.
10 Hoermann R, Gerbes AL, Spoettl G, Jüngst D, Mann K. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors. Cancer Res. 1992;52(6):1520–4.
11 Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. Clin Chem. 1992;38:1981–7.
12 Stenman UH, Alfthan H, Ranta T, Vartiainen E, Jalkanen J, Seppala M. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab. 1987;64:730–6.
13 Cole LA, Sasaki Y, Muller CY. Normal production of human chorionic gonadotropin in menopause. N Engl J Med. 2007;356:1184–6.
14 Hoshi S, Suzuki K, Ishidoya S, Ohyama C, Sato M, Namima T, et al. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients. Int J Urol. 2000;7:218–23.
15 Stenman UH, Alfthan H, Blomqwist C,Hotakainen K,Lempiäinen A. Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma. Clin Chem. 2007;53(8):1560–1.
16 Hoermann R, Spoettl G, Moncayo R, Mann K. Evidence for the presence of human chorionic gonadotropin (hCG) and free Beta- subunit of hCG in the human pituitary. J Clin Endocrinol Metab. 1990;71:179–86.
17 Albany C, Einhorn L. Pitfalls in management of patients with germ cell tumors and slight elevation of serum α-fetoprotein. J Clin Oncol. 2014;32(19):2114–5.
18 Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N et al. The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor. J Cancer Res Clin Oncol. 2017 Sep 13.
doi:10.1007/s00432-017-2520-5.